Atlantic Pharmaceuticals, Inc., is a privately held emerging specialty pharmaceutical company dedicated to the discovery, development and commercialization of innovative late stage therapies utilized in the treatment of substance abuse and pain related conditions and diseases. Our current therapies focus on oral abuse resistant delivery systems and injectable depots for sustained analgesia and monitored opiate maintenance for drug abuse rehabilitation.